Skip to Content

Pfizer STN 37.5 mg (Sutent 37.5 mg)

Generic Name: sunitinib

Pill imprint Pfizer STN 37.5 mg has been identified as Sutent 37.5 mg.

Sutent is used in the treatment of renal cell carcinoma; gastrointestinal stromal tumor; pancreatic cancer and belongs to the drug classes multikinase inhibitors, VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Sutent 37.5 mg is not a controlled substance under the Controlled Substance Act (CSA).

Sutent 37.5 mg Pfizer STN 37.5 mg
Discount Card Promo
Sutent
Generic Name:
sunitinib
Imprint:
Pfizer STN 37.5 mg
Strength:
37.5 mg
Color:
Yellow
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Multikinase inhibitors
VEGF/VEGFR inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Manufacturer:
Pfizer U.S. Pharmaceuticals Group

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide